Physician
Abdo, Nasser
Abdo, Nasser was paid $1K by Medicaid between Jan 2018 and Dec 2024, across 56 billing codes. Its largest line is 99213, doctor's office visit, returning patient (routine) — 73% of everything it billed.
33Billing provider infoABDO, NASSER
SYLMAR, CA 91342
SYLMAR, CA 91342
33aNPI1306911649assigned 11/21/2006
33bProvider typeInternal Medicine Physician
28Total paid$1K
24GClaims38,240
24DCodes billed56
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Internal Medicine Physician providers in California
Rank by total paid#1,992 of 2,679
Median peer was paid$13K
This provider vs. median0.1×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 3,780 | $775.58 | |
| 2019 | 2,500 | $489.76 | |
| 2020 | 5,203 | $0.00 | |
| 2021 | 6,682 | $0.00 | |
| 2022 | 6,680 | $0.00 | |
| 2023 | 5,662 | $0.00 | |
| 2024incomplete | 7,733 | $0.00 |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 73% | 2,474 | 2,070 | $918.25 |
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 16% | 1,330 | 1,137 | $201.13 |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | 6.7% | 2,426 | 2,051 | $85.08 |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | 4.8% | 366 | 310 | $60.88 |
| 85610 | 0% | 199 | 153 | $0.00 | |
| 84460 | 0% | 289 | 289 | $0.00 | |
| 80061 | Lipid panel | 0% | 3,139 | 3,124 | $0.00 |
| 84450 | 0% | 523 | 521 | $0.00 | |
| 99442 | 0% | 780 | 756 | $0.00 | |
| 97110 | Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion | 0% | 120 | 65 | $0.00 |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | 0% | 88 | 88 | $0.00 |
| 82274 | 0% | 347 | 347 | $0.00 |
44 more codes
| 86703 | 0% | 628 | $0.00 | |
| 3078F | 0% | 603 | $0.00 | |
| 1033F | 0% | 101 | $0.00 | |
| 82540 | 0% | 449 | $0.00 | |
| 77067 | Screening mammography, bilateral, including computer-aided detection | 0% | 51 | $0.00 |
| 99215 | Doctor's office visit, returning patient (complex) | 0% | 196 | $0.00 |
| 84439 | 0% | 13 | $0.00 | |
| 3077F | 0% | 138 | $0.00 | |
| 82565 | 0% | 54 | $0.00 | |
| 77062 | 0% | 24 | $0.00 | |
| 86480 | 0% | 13 | $0.00 | |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | 0% | 31 | $0.00 |
| 3051F | 0% | 12 | $0.00 | |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | 0% | 1,605 | $0.00 |
| 80048 | Basic metabolic panel (calcium, ionized) | 0% | 1,753 | $0.00 |
| 99443 | 0% | 403 | $0.00 | |
| 87522 | Neg quan hep c or qual rna | 0% | 127 | $0.00 |
| 36415 | Collection of venous blood by venipuncture | 0% | 7,061 | $0.00 |
| 80053 | Comprehensive metabolic panel | 0% | 2,715 | $0.00 |
| 83036 | Hemoglobin; glycosylated (A1C) | 0% | 3,871 | $0.00 |
| 85027 | 0% | 681 | $0.00 | |
| 82043 | 0% | 449 | $0.00 | |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 0% | 2,174 | $0.00 |
| 3079F | 0% | 115 | $0.00 | |
| 99441 | 0% | 324 | $0.00 | |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | 0% | 714 | $0.00 |
| 4450F | 0% | 12 | $0.00 | |
| 3075F | 0% | 141 | $0.00 | |
| 90686 | 0% | 169 | $0.00 | |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | 0% | 88 | $0.00 |
| U0005 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 | 0% | 28 | $0.00 |
| 87088 | 0% | 25 | $0.00 | |
| 84443 | Thyroid stimulating hormone (TSH) | 0% | 110 | $0.00 |
| 1111F | 0% | 117 | $0.00 | |
| 3074F | 0% | 498 | $0.00 | |
| 83735 | 0% | 75 | $0.00 | |
| 1220F | 0% | 84 | $0.00 | |
| 86780 | 0% | 55 | $0.00 | |
| 81001 | 0% | 27 | $0.00 | |
| 90656 | 0% | 69 | $0.00 | |
| 3044F | 0% | 319 | $0.00 | |
| 3080F | 0% | 13 | $0.00 | |
| 86592 | 0% | 12 | $0.00 | |
| 82728 | 0% | 12 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.